{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:32:52Z","timestamp":1784291572418,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100012605","name":"George Sarlo Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100012605","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Council on Spiritual Practices Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100006623","name":"San Francisco Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020782","name":"Riverstyx Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100020782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013057","name":"Heffter Research Institute","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100013057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oppenheimer Family POPC Research Grants Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Nikean Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Carey and Claudia Turnbull Family Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"T. Cody Swift, Dr. Bronner\u2019s, the Griffin Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"the Flourish Trust","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for demoralisation in terminally ill patients receiving home hospice care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this open-label pilot trial, 4607 home hospice patients at a large community hospice were screened over 22 months; 66 were approached, 15 enrolled and 10 received psilocybin. Participants completed two home-based preparation sessions, a single 25\u2009mg oral psilocybin session at an inpatient hospice facility, and two home-based integration sessions. Feasibility was assessed through recruitment, retention and acceptability. Safety was evaluated via adverse event monitoring, and preliminary efficacy was assessed using changes in demoralisation scores and other psychosocial measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The intervention was well tolerated, with no serious adverse events attributed to psilocybin. At week 3, demoralisation scores significantly decreased (mean reduction: 8.8 points, p=0.0196), despite ongoing clinical decline. Grief- and peace-related themes were prominent during psilocybin sessions. While six participants rated the treatment favourably on the Reaction to Research Participation Questionnaire global evaluation factor, three rated neutral on one or more items, suggesting that the emotional intensity and demands of the intervention may influence acceptability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides initial evidence that PAT can be feasibly and safely integrated into hospice care for terminally ill patients. Further research is needed to optimise delivery and further assess therapeutic potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005773","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:20:12Z","timestamp":1762194012000},"page":"423-433","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct04950608","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-6736","authenticated-orcid":false,"given":"Yvan","family":"Beaussant","sequence":"first","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Sager","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Brennan","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"},{"name":"School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Kristan","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ljuslin","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Mazzola","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5595-100X","authenticated-orcid":false,"given":"Morgan Ellasandra","family":"Murphy","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Nigam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Department of Psychiatry, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden D","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Care Dimensions, Danvers, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Sanders","sequence":"additional","affiliation":[{"name":"McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen G","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Sholevar","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5911-2204","authenticated-orcid":false,"given":"Lisa","family":"Summer","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Anna Maria College, Paxton, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alifia","family":"Waliji-Banglawala","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Yudilevich-Espinoza","sequence":"additional","affiliation":[{"name":"Care Dimensions, Danvers, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Tulsky","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2026022702201308000_16.2.423.1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpainsymman.2019.04.012","article-title":"Prevalence, Severity, and Correlates of Symptoms of Anxiety and Depression at the Very End of Life","volume":"58","author":"Kozlov","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026022702201308000_16.2.423.2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/082585970101700103","article-title":"Demoralization syndrome--a relevant psychiatric diagnosis for palliative care","volume":"17","author":"Kissane","year":"2001","journal-title":"J Palliat Care"},{"key":"2026022702201308000_16.2.423.3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S1478951519000191","article-title":"Exploring demoralization in end-of-life cancer patients: Prevalence, latent dimensions, and associations with other psychosocial variables","volume":"17","author":"Bovero","year":"2019","journal-title":"Palliat Support Care"},{"key":"2026022702201308000_16.2.423.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.05.010"},{"key":"2026022702201308000_16.2.423.5","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1002\/cncr.30749","article-title":"The association of demoralization with mental disorders and suicidal ideation in patients with cancer","volume":"123","author":"Vehling","year":"2017","journal-title":"Cancer"},{"key":"2026022702201308000_16.2.423.6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pon.3417","article-title":"Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model","volume":"23","author":"Vehling","year":"2014","journal-title":"Psychooncology"},{"key":"2026022702201308000_16.2.423.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2014.07.008"},{"key":"2026022702201308000_16.2.423.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.22.2907"},{"key":"2026022702201308000_16.2.423.9","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0140"},{"key":"2026022702201308000_16.2.423.10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2215-0366(14)70313-X","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data","volume":"1","author":"Walker","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"2026022702201308000_16.2.423.11","article-title":"Antidepressants for depression in physically ill people","volume":"2010","author":"Rayner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026022702201308000_16.2.423.12","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"2026022702201308000_16.2.423.13","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"2026022702201308000_16.2.423.14","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"2026022702201308000_16.2.423.15","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119897615"},{"key":"2026022702201308000_16.2.423.16","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817715966"},{"key":"2026022702201308000_16.2.423.17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0022167817706884","article-title":"Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis","volume":"57","author":"Belser","year":"2017","journal-title":"J Humanist Psychol"},{"key":"2026022702201308000_16.2.423.18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaoncol.2023.0351","article-title":"Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder","volume":"9","author":"Agrawal","year":"2023","journal-title":"JAMA Oncol"},{"key":"2026022702201308000_16.2.423.19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"key":"2026022702201308000_16.2.423.20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cncr.35024","article-title":"Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis","volume":"130","author":"Beaussant","year":"2024","journal-title":"Cancer"},{"key":"2026022702201308000_16.2.423.21","doi-asserted-by":"crossref","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"eClinicalMedicine"},{"key":"2026022702201308000_16.2.423.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.06.006"},{"key":"2026022702201308000_16.2.423.23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2026022702201308000_16.2.423.24","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817711304"},{"key":"2026022702201308000_16.2.423.25","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"2026022702201308000_16.2.423.26","unstructured":"CTCAE and AE reporting - NCI. 2025. Available: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events [Accessed 10 Jul 2025]."},{"key":"2026022702201308000_16.2.423.27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/02698811241265756","article-title":"A framework for assessment of adverse events occurring in psychedelic-assisted therapies","volume":"38","author":"Palitsky","year":"2024","journal-title":"J Psychopharmacol"},{"key":"2026022702201308000_16.2.423.28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111704"},{"key":"2026022702201308000_16.2.423.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-12-941"},{"key":"2026022702201308000_16.2.423.30","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/cncr.30012","article-title":"Refinement and revalidation of the demoralization scale: The DS-II-external validity","volume":"122","author":"Robinson","year":"2016","journal-title":"Cancer"},{"key":"2026022702201308000_16.2.423.31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1177\/1049909118763793","article-title":"Psychometric Properties of the FACIT-Pal 14 Administered in an Outpatient Palliative Care Clinic","volume":"35","author":"Shinall","year":"2018","journal-title":"Am J Hosp Palliat Care"},{"key":"2026022702201308000_16.2.423.32","unstructured":"Patient-reported outcomes measurement information system. Pain interference: a brief guide to the PROMIS pain interference instruments; Bethesda, MD, Available: http:\/\/www.healthmeasures.net\/images\/PROMIS\/manuals\/PROMIS_Pain_Interference_Scoring_Manual.pdf"},{"key":"2026022702201308000_16.2.423.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2026022702201308000_16.2.423.34","unstructured":"Reker GT . The life attitude pro\ufb01le- revised (LAP-R). Peterborough, ON Student Psychologists Press; 1992."},{"key":"2026022702201308000_16.2.423.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.011"},{"key":"2026022702201308000_16.2.423.36","unstructured":"Patient-reported outcomes measurement information system. social isolation: a brief guide to the promis social isolation instruments. Bethesda, MD, 2015. Available: http:\/\/www.healthmeasures.net\/images\/PROMIS\/manuals\/PROMIS_Social_Isolation_Scoring_Manual.pdf"},{"key":"2026022702201308000_16.2.423.37","doi-asserted-by":"crossref","unstructured":"Peterman A , Fitchett G , Brady M , et al . Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002. doi:10.1207\/S15324796ABM2401_06","DOI":"10.1037\/t69868-000"},{"key":"2026022702201308000_16.2.423.38","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115609019"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:22:20Z","timestamp":1772187740000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/spcare-2025-005773"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005773","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}